Health Care & Life Sciences » Pharmaceuticals | Kadmon Holdings Inc.

Kadmon Holdings Inc.

Kadmon Holdings Inc.
Stock Exchange New York Stock Exchange
EPS
$0.23
Market Cap
$261.55 M
Shares Outstanding
129.48 M
Public Float
98.28 M

Profile

Address
450 East 29th Street
New York New York 10016
United States
Employees -
Website http://www.kadmon.com
Updated 07/08/2019
Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. Its products include Ribasphere RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N.

Financials

View All

Anastasios G. Konidaris
Independent Director
Steven Meehan
Independent Director